Neutrophil extracellular traps (NETs), crucial in immune defense mechanisms, are
renowned for their propensity to expel decondensed chromatin embedded with inflammatory …

Antiphospholipid syndrome (APS) consists of thrombotic, non-thrombotic and obstetric
clinical manifestations developing in individuals with persistent antiphospholipid antibodies …

Systemic lupus erythematosus (SLE) and antiphospholipid syndrome (APS) are two related
autoimmune diseases. In recent years, there has been sufficient evidence to suggest that …

Antibodies against phospholipid (aPL)-binding proteins, in particular, beta 2 glycoprotein I
(β2GPI), are diagnostic/classification and pathogenic antibodies in antiphospholipid …

Lupus nephritis (LN) is a severe complication of systemic lupus erythematosus (SLE) and is
considered one of the leading causes of mortality. Multiple immunological pathways are …

Anti-phospholipid autoantibodies are a group of antibodies that can specifically bind to
anionic phospholipids and phospholipid protein complexes. Recent studies have reported …

High-dose radiation therapy is a widely used clinical strategy to inhibit tumor growth.
However, the rapid generation of excessive reactive oxygen species (ROS) triggers the …

The article presents a study by Zuo et al that examines autoantibody expression in patients
with antiphospholipid antibodies (aPL), particularly those with antiphospholipid syndrome …

In this review, we discuss the current evidence on classic and newer oral anticoagulant
therapy, older drugs such as HCQ and statins, and new potential treatment targets in APS …

Growing evidence has suggested the contribution of NET dysregulation to the pathogenesis
of several inflammatory rheumatic diseases. Further research is warranted in regard to …